Physician profile
Michael L Monter
NPI 1497081228
$2,299.45
in general payments reported to CMS, 2019-2025
26 companies · $353 in 2025
The $353 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $416 · 2021: $771 · 2022: $140 · 2023: $70.92 · 2024: $42.81 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $394.57 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $326.54 | 2020-2022 | |
| Smith+Nephew, INC. | $217.98 | 2019-2021 | |
| Acera Surgical, INC. | $173.58 | 2022-2025 | Restrata Wound Matrix |
| Organogenesis INC. | $165.56 | 2019-2021 | |
| Abbott Laboratories | $135.12 | 2021 | |
| Wright Medical Technology, INC. | $135.00 | 2019-2020 | |
| Misonix INC | $124.37 | 2019-2021 | |
| Aroa Biosurgery Incorporated | $122.16 | 2025 | |
| Averitas Pharma INC. | $75.84 | 2024-2025 | Qutenza |
| Horizon Therapeutics Plc | $67.64 | 2020 | |
| Kci USA, INC. | $53.04 | 2019-2021 | |
| Zyla Life Sciences, INC. | $38.99 | 2019-2020 | |
| Sebela Pharmaceuticals INC. | $35.95 | 2019 | |
| Glenmark Therapeutics INC. | $32.00 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $28.76 | 2023 | Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $24.84 | 2020-2021 | |
| Medtronic, INC. | $22.45 | 2023 | Venaseal |
| Access Pro Medical, LLC | $21.88 | 2025 | Matriderm |
| Progenacare Global, LLC | $19.71 | 2023 | |
| Orthofix Medical, INC. | $19.71 | 2025 | Physio-Stim |
| Paratek Pharmaceuticals, INC. | $14.14 | 2021 | |
| Merck Sharp & Dohme LLC | $13.00 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $12.89 | 2021 | |
| Kerecis Limited | $12.16 | 2021 | |
| Convatec INC. | $11.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Monter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.